64
total announcements
JSLL.NS · 15 min delayed
Key Stats · Yahoo Finance · as of 15 Oct 2026
Market Cap
₹4,783 Cr
P/E (TTM)
20.3
P/E (Forward)
10.7
EPS (TTM)
₹18.98
52W Low
₹359.75
52W High
₹835.00
Dividend Yield
1.15%
Beta
1.04
Price / Book
10.2
Debt / Equity
27.3
Revenue (TTM)
₹851 Cr
Gross Margin
88.39%
Operating Margin
34.17%
Jeena Sikho Lifecare Limited
Jeena Sikho Lifecare Limited has informed the Exchange regarding the allotment of 23,374 shares under the Employee Stock Option Scheme 2024 (ESOS 2024) to eligible employees.
Jeena Sikho Lifecare Limited
Jeena Sikho Lifecare Limited has informed the Exchange regarding allotment of 23,374 Equity shares under the Jeena Sikho Lifecare Limited Employee Stock Option Scheme 2024 (ESOS 2024). The paid-up equity share capital of the Company stands increased from Rs. 24,86,01,460/- to Rs. 24,86,48,208/-.
Jeena Sikho Lifecare Limited
Jeena Sikho Lifecare Limited has submitted a compliance certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, for the quarter and half-year ended September 30, 2026.
Jeena Sikho Lifecare Limited
Jeena Sikho Lifecare Limited has launched seven new Ayurvedic healthcare, wellness and nutraceutical products, including tablets, oil, and plant protein products.
Jeena Sikho Lifecare Limited
Jeena Sikho Lifecare Limited has received NABH accreditation for its Raipur hospital, adhering to nationally recognized standards for quality healthcare delivery, patient safety, and operational excellence.
Jeena Sikho Lifecare Limited
Jeena Sikho Lifecare Limited has submitted the Exchange a copy Srutinizers report of 9th Annual General Meeting held on September 28, 2026, and informed the Exchange regarding voting results.
Jeena Sikho Lifecare Limited
Jeena Sikho Lifecare Limited has informed the Exchange about Disclosure under Regulation 29(2) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, regarding the purchase of 25,000 equity shares of the Company through the open market on 29th September, 2026.
Jeena Sikho Lifecare Limited
Jeena Sikho Lifecare Limited has informed the Exchange about Disclosure under Regulation 29(2) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, regarding the purchase of 35,000 equity shares of the Company through the open market on 28th September, 2026, by Bhavna Grover, Promoter, Whole Time Director of the Company.
Jeena Sikho Lifecare Limited
Jeena Sikho Lifecare Limited has informed the Exchange regarding Proceedings of 9th Annual General Meeting held on September 28, 2026. The meeting was held to transact the businesses as stated in the Notice of the 9th AGM dated August 31, 2026. The company declared a final dividend of ₹4.50/- per equity share and reappointed several directors.
Jeena Sikho Lifecare Limited
Jeena Sikho Lifecare Limited has closed its trading window for directors, KMPs, and connected persons and their immediate relatives from October 1, 2026, until 48 hours after the declaration of unaudited financial results for the quarter and half year ended September 30, 2026.
Jeena Sikho Lifecare Limited
Jeena Sikho Lifecare Limited has received in-principle approval from BSE Limited for listing up to 6,50,000 equity shares under the Employee Stock Option Scheme 2024.
Jeena Sikho Lifecare Limited
Jeena Sikho Lifecare Limited has informed the Exchange about the schedule of an analyst/institutional investor meet/conference under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Jeena Sikho Lifecare Limited
Jeena Sikho Lifecare Limited has launched new products.
Jeena Sikho Lifecare Limited
Jeena Sikho Lifecare Limited has postponed the commencement of commercial operations at its new hospital facility in Lucknow, Uttar Pradesh, from June 2026 to December 2026 due to operational arrangements and readiness of the premises.
Jeena Sikho Lifecare Limited
Jeena Sikho Lifecare Limited has postponed the commencement of commercial operations at its new Day Care Clinic in Ayodhya, Uttar Pradesh, from the expected date to the end of September 2026.
Jeena Sikho Lifecare Limited
Jeena Sikho Lifecare Limited has received NABH accreditation for its Pune Hospital, adhering to national standards for quality healthcare delivery, patient safety, and operational excellence.
Jeena Sikho Lifecare Limited
Jeena Sikho Lifecare Limited has launched two new Ayurvedic products: Acharya Ji's Jeevanodya Vati – 60 Tablets and Acharya Ji's Ojavardhan Vati – 60 Tablets, expanding its portfolio of Ayurvedic healthcare and wellness products.
Jeena Sikho Lifecare Limited
Jeena Sikho Lifecare Limited has informed the Exchange about Copy of Newspaper Publication for the Notice of 9th AGM, E-Voting Information and Cut-off Date.
Jeena Sikho Lifecare Limited
Jeena Sikho Lifecare Limited has informed the Exchange about Intimation wrt web-link through which the Integrated Annual Report of the Company for the Financial Year 2025-26 can be accessed.
Jeena Sikho Lifecare Limited
Jeena Sikho Lifecare Limited has submitted its Business Responsibility and Sustainability Report for the financial year 2025-26, as per SEBI listing regulations.